Ewer, M S

de Azambuja, E; Agostinetto, E; Procter, M; Eiger, D; Pondé, N; Guillaume, S; Parlier, D; Lambertini, M; Desmet, A; Caballero, C; Aguila, C; Jerusalem, G; Walshe, J M; Frank, E; Bines, J; Loibl, S; Piccart-Gebhart, M; Ewer, M S; Dent, S; Plummer, C; ... (2023). Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial. ESMO open, 8(1), p. 100772. BMJ 10.1016/j.esmoop.2022.100772

Harbeck, N; Ewer, M S; De Laurentiis, M; Suter, T M; Ewer, S M (2011). Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy. Annals of oncology, 22(6), pp. 1250-1258. Oxford: Oxford University Press 10.1093/annonc/mdq543